3beta,7alpha,12alpha-Trihydroxychol-5-en-24-oic Acid

Metabolite details

Identifier

NKRVAQNWPRPQDK-SZHOAPCDSA-N

InChI Key

NKRVAQNWPRPQDK-SZHOAPCDSA-N

IUPAC name

(4R)-4-[(3S,7S,8R,9S,10R,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

Preferred name

3beta,7alpha,12alpha-Trihydroxychol-5-en-24-oic Acid

INN name

—

Synonym

—

ChEBI

CHEBI:184261

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Metabolism Disorder Promotes Isoproterenol-induced Myocardial Injury in Mice with High Temperature and High Humidity and High-Fat Diet
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis

Observed in differential profiles

• Control_vs_Exercise
• G1_PBS_vs_G2_DSS
• Control_vs_Isoproterenol
• Normal_vs_Neural_Tube_Defect
• Control_vs_ZYP_High_Dose